OpenVSafe by OpenVAERS
Search V-safe

7W2-13138-68989

2 vaccinations 13 coded responses 18 check-ins 13 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
088 / NJ
Registered
2021-03-24
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-24
    Registered in v-safe
  2. 2021-03-24
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-25
    Survey response — days 1–6 daily, dose 1
    MedDRA: Myalgia, Pain in extremity — Feeling: Good · Muscle or body aches
    Free text: Sore muscle in arm that received shot
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  5. 2021-03-28
    Survey response — days 1–6 daily, dose 1
    MedDRA: Diabetes mellitus, Insulin resistance, Pre-existing disease — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Im a Type 1 Diabetic and have been fairly insulin resistant since the shot
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-29
    Survey response — days 1–6 daily, dose 1
    MedDRA: Insulin resistance, Pre-existing disease, Type 1 diabetes mellitus — Feeling: Good · Fatigue or tiredness
    Free text: Continuing to experience insulin resistance as a Type 1 Diabetic
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-30
    Survey response — days 1–6 daily, dose 1
    MedDRA: Diabetes mellitus, Insulin resistance, Pre-existing disease — Feeling: Good · Headache, Fatigue or tiredness
    Free text: As a Type 1 Diabetic, still somewhat insulin resistant
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-01
    Survey response — day 7, dose 1
    MedDRA: Pre-existing disease — Feeling: Good · Fatigue or tiredness
    Free text: Still slightly insulin resistant (Type 1 Diabetes)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-07
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-04-14
    Dose 2 — Pfizer-BioNTech
  11. 2021-04-14
    Survey response — day 0, dose 2
    MedDRA: Condition aggravated, Insulin resistance, Pre-existing disease — Feeling: Good · Fatigue or tiredness
    Free text: As a Type 1 Diabetic, began experiencing some insulin resistance since I received the 2nd shot
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pre-existing disease — Feeling: Good · Fatigue or tiredness
    Free text: As a type 1 diabetic, having insulin resistance
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Insulin resistance, Pre-existing disease — Feeling: Good · Fatigue or tiredness
    Free text: As a Type 1 Diabetic, experiencing some insulin resistance
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-04-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Insulin resistance, Pre-existing disease, Type 1 diabetes mellitus — Feeling: Good · Fatigue or tiredness
    Free text: As a Type 1 Diabetic, experiencing some insulin resistance
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Insulin resistance, Pre-existing disease — Feeling: Good
    Free text: As a Type 1 Diabetic, experiencing some insulin resistance
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pre-existing disease — Feeling: Good
    Free text: As a Type 1 Diabetic, still experiencing some insulin resistance
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-20
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pre-existing disease — Feeling: Good
    Free text: As a Type 1 Diabetic, still experiencing some insulin resistance
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-04-23
    Survey response — day 7, dose 2
    MedDRA: Diabetes mellitus, Insulin resistance, Pre-existing disease — Feeling: Good
    Free text: As a Type 1 Diabetic, still experiencing some insulin resistance
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-04-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-07-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-10-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-24Pfizer-BioNTech
22021-04-14Pfizer-BioNTech

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-25

Systemic reaction (other): Sore muscle in arm that received shot

2021-03-28

Systemic reaction (other): Im a Type 1 Diabetic and have been fairly insulin resistant since the shot

2021-03-29

Systemic reaction (other): Continuing to experience insulin resistance as a Type 1 Diabetic

2021-03-30

Systemic reaction (other): As a Type 1 Diabetic, still somewhat insulin resistant

Release 6 — day 7, dose 1

2021-04-01

Systemic reaction (other): Still slightly insulin resistant (Type 1 Diabetes)

Release 7 — day 0, dose 2

2021-04-14

Systemic reaction (other): As a Type 1 Diabetic, began experiencing some insulin resistance since I received the 2nd shot

Release 7 — days 1–6 daily, dose 2

2021-04-15

Systemic reaction (other): As a type 1 diabetic, having insulin resistance

2021-04-16

Systemic reaction (other): As a Type 1 Diabetic, experiencing some insulin resistance

2021-04-17

Systemic reaction (other): As a Type 1 Diabetic, experiencing some insulin resistance

2021-04-18

Systemic reaction (other): As a Type 1 Diabetic, experiencing some insulin resistance

2021-04-19

Systemic reaction (other): As a Type 1 Diabetic, still experiencing some insulin resistance

2021-04-20

Systemic reaction (other): As a Type 1 Diabetic, still experiencing some insulin resistance

Release 7 — day 7, dose 2

2021-04-23

Systemic reaction (other): As a Type 1 Diabetic, still experiencing some insulin resistance

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROCondition aggravated ✓ ✓ ✓
SRODiabetes mellitus ✓ ✓ ✓
SROInsulin resistance ✓ ✓ ✓
SROMyalgia ✓ ✓ ✓
SROPain in extremity ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROType 1 diabetes mellitus ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release